NTBL:US
$0.248
-
0.00%

Notable Labs Ltd.
News & Events

Last updated: Jun 25, 2025, 7:36 PM ET

  1. Notable Labs to Present Data on September 4th at SOHO 2024

    GlobeNewswire AUG 29, 2024 7:30 AM EDT
    Society of Hematologic Oncology (SOHO) session to highlight volasertib program Phase 2 ...
    READ ARTICLE
  2. Notable Labs Announces CEO Transition

    GlobeNewswire AUG 26, 2024 4:05 PM EDT
    Thomas Bock, MD resigns as CEO; Joseph Wagner, PhD, CSO, appointed interim CEO Company ...
    READ ARTICLE
  3. Notable Labs Receives FDA Clearance to Proceed Further with Volasertib Phase 2 Study

    GlobeNewswire JUL 24, 2024 7:30 AM EDT
    FOSTER CITY, Calif., July 24, 2024 (GLOBE NEWSWIRE) -- Notable Labs, Ltd. (Nasdaq: NTBL) (“...
    READ ARTICLE
  4. SHAREHOLDER ALERT: Rigrodsky Law, P.A. Is Investigating Vascular Biogenics Ltd. Merger

    Newsfile FEB 23, 2023 3:36 PM EST
    Wilmington, Delaware--(Newsfile Corp. - February 23, 2023) - Rigrodsky Law, P.A. is investigating...
    READ ARTICLE
  5. Investor Network: Vascular Biogenics Ltd. to Host Earnings Call

    ACCESS Newswire AUG 14, 2017 6:01 AM EDT
    NEW YORK, NY / ACCESSWIRE / August 14, 2017 / Vascular Biogenics Ltd. (NASDAQ: VBLT ) wil...
    READ ARTICLE
  6. Analyst Insights behind Price Movement - Research on Vascular Biogenics, Hutchinson Technology, Tonix Pharmaceuticals and Nymox Pharmaceutical

    ACCESS Newswire NOV 23, 2015 8:40 AM EST
    NEW YORK, NY / ACCESSWIRE / November 23, 2015 / Moments ago, Trader's Choice released new re...
    READ ARTICLE

Upcoming Events

Get notified of Notable Labs Ltd.’s latest announcements, news, and event dates.
  • Upcoming earnings announcement

    Not Available
  • Upcoming dividend payout

    Not Available
  • Upcoming stock splits

    Not Available